[1]
M. Dolzhenko, “Use of Ethylmethylhydroxypyridine in Patients Presenting with Myocardial Infarction: Antiischemic, Antidepressant, Anxiolytic Effects”, FMEP, no. 4, pp. 67–74, Oct. 2016.